Anemia in Elderly Sudanese Lung Cancer Patients Treated with


By Fathelrahman Mahdi Hassan, Eman A. Weeda.


Background: Cancer among Sudanese citizens has been rapidly rising since 1999 till this year and at least 80% of all patients undergo chemotherapy will develop anemia as a complication of these drugs. Aim: To publish the Sudanese patients Hemodynamic observations during various regimen of Chemotherapy in lung cancer. Settings and Design: This prospective observational study was conducted in the major specialized medical Radiation and Isotope Center Khartoum (RICK). Materials and Methods: Eighty patients diagnosed of having lung cancer admitted from June 2008 to September 2009. Patients enrolled in the study were required to be 60 years old and to have a confirmed diagnosis of lung cancer, for which they were undergoing concomitantly radio - chemotherapy. Statistical Analysis: Analysis of data obtained by independent sample test (t-test) was performed for equality of these mean probability value. Results: Prior treatment pre cycle I; 56.2% of patients were normal, 38.8% with mild anemia and 5.0% were had a moderate anemia. Post cycle I treatment; the normal were declined to only 9.0% and mild anemia were the highest percentage 55% followed by 28.5% for moderate anemia and 7.5% showed severe anemia. Post cycle II about 27.5% of patient showed normal hemoglobin while the majority of them 72.5% had moderate anemia. Conclusion: A correlation of hemoglobin values after completion of therapy to overall treatment was found as a decline in range of (1 to 2 g/dl). Anemia has been demonstrated to be a predictive indicator of response to chemo radiotherapy in lung tumors.


  • Bunn PA Jr, Lilenbaum R. Chemotherapy for elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 2003; 95: 341-3.
  • Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 2000; 35: 181-200.
  • Balducci L, Hardy CL. Anemia of aging: a model of erythropoiesis in cancer patients. Cancer Control 1998; 5(Suppl 1): 17-21.
  • Ania BJ, Suman VJ, Fairbanks VF, Rademacher DM, Melton LJ 3rd. Incidence of anemia in older people: an epidemiologic study in a well- defined population. J Am Geriatr Soc 1997; 45: 825-31.
  • Ludwig H, Fritz E. Anemia in cancer patients. Semin Oncol 1998; 25: 2-6.
  • Chaves PHM, Ashar B, Guralnik JM, Fried LP. Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated? J Am Geriatr Soc 2002; 50: 1257-64.
  • Gutstein HB. The biologic basis of fatigue. Cancer 2001; 92(Suppl): 1678-83.
  • Pickett JL, Theberge DC, Brown WS, Schweitzer SU, Nissenson AR. Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis 1999; 33: 1122-30.
  • Lichtin A. The ASH/ASCO clinical guidelines on the use of erythropoietin. Best Pract Res Clin Haematol 2005; 18: 433-8.
  • Shen JG, Cheong JH, Hyung WJ, Kim J, Choi SH, Noh SH. Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer. J Surg Oncol 2005; 91: 126-30
  • Kosmidis P, Krzakowski M, The ECAS Investigators. Anemia Profiles in Patients with Lung Cancer: What Have We Learned From the European Cancer Anaemia Survey (ECAS)? Lung Cancer 2005; 50: 401-12
  • Dubray B, Mosseri V, Brunin F, et al. Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology 1996; 201: 553-8
  • Coates TD, Baehner RL. Leukocytosis and leukopenia. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Eds. Hematology basic principles and practice. 1 st ed. NewYork: Churchill Living Stone 1991; p. 552
  • Mancuso A, Migliorino M, De Santis S, Saponiero A, De Marinis A. Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Ann Oncol 2006; 17(1): 146-50.